“We have seen remarkable progress as far as AI’s impact on drug discovery, from target identification and drug design to preclinical safety and beyond—and this innovation has catalyzed and ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma.

This work will involve the use of quantum computers and AI in collaboration with Alán Aspuru-Guzik's lab at U of T and Insilico Medicine, a global leader in generative AI drug discovery." ...

This innovation could help accelerate drug discovery and enhance the efficiency of medicinal chemistry. A team of chemists from Scripps Research and Rice University has unveiled a novel method to ...